Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Pain, Postoperative 2Neurotoxicity Syndromes 2Neoplasms 2Colonic Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Seizures 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Primary Immunodeficiency Diseases 1Paclitaxel-induced Neuropathy 1Myoma 1Mesothelioma 1Infections 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Brain Neoplasms 1Anesthesia 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Magnesium Sulfate × Clear all
NCT05663801 2024-12-27

Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy

Beni-Suef University

Phase 2 Completed
72 enrolled
Tumor-Agnostic

Neoplasms

NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡